Does GLOFITAMAB Cause Disease progression? 183 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 183 reports of Disease progression have been filed in association with GLOFITAMAB (Columvi). This represents 16.4% of all adverse event reports for GLOFITAMAB.
183
Reports of Disease progression with GLOFITAMAB
16.4%
of all GLOFITAMAB reports
78
Deaths
39
Hospitalizations
How Dangerous Is Disease progression From GLOFITAMAB?
Of the 183 reports, 78 (42.6%) resulted in death, 39 (21.3%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLOFITAMAB. However, 183 reports have been filed with the FAERS database.
What Other Side Effects Does GLOFITAMAB Cause?
Cytokine release syndrome (415)
Off label use (129)
Death (125)
Neutropenia (109)
Pyrexia (78)
Febrile neutropenia (69)
Covid-19 (62)
Drug ineffective (53)
Immune effector cell-associated neurotoxicity syndrome (45)
Infection (44)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which GLOFITAMAB Alternatives Have Lower Disease progression Risk?
GLOFITAMAB vs GLOFITAMAB-GXBM
GLOFITAMAB vs GLUCAGON
GLOFITAMAB vs GLUCAGON\GLUCAGON\WATER
GLOFITAMAB vs GLUCARPIDASE
GLOFITAMAB vs GLUCOPHAGE